Skip to content

Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics

Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03237130
Enrollment
133
Registered
2017-08-02
Start date
2017-02-15
Completion date
2020-05-15
Last updated
2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagus Cancer

Keywords

esophagus cancer; radiomics; computed tomograpy

Brief summary

This study proposes to establish a CT radiomics-based prediction model for identifying metastasis lymph nodes in esophageal cancer.

Detailed description

This study proposes to establish an image feature extraction and selection method for identifying lymph node metastasis of esophageal cancer.The study will consider the relationship between the main lesion and the suspected lymph node, extract association characteristics in order to improve the sensitivity and specificity of the CT radiomics-based prediction model for identifying metastasis lymph nodes. The study includes the construction of CT radiomics-based prediction model and the validation of the prediction model.

Interventions

PROCEDUREpreoperative enhanced chest CT examination

Each patient will receive preoperative enhanced chest CT examination, and their CT images will be used for analysis

Sponsors

Peking University Cancer Hospital & Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* pathologically proven esophageal cancer * scheduled to preoperative enhanced chest CT and undergo surgery * sign the patient informed consent

Exclusion criteria

* failed to receive preoperative enhanced chest CT or undergo surgery * inavailable pathological results for local lymph node status * inquality of CT images for feature extraction * patient quit

Design outcomes

Primary

MeasureTime frameDescription
pathological local lymph node statusPathologic evaluation will be performed for each patient within 1 week after surgerypathological lymph node status is defined as lymph node metastasis exist or not

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026